The dermoscopy era is developing momentum. Our greater understanding of the morphological features seen with dermoscopy has corresponded with an exponential rise in dermoscopy publications. Publications have in- cluded conditions as diverse as inf lammatory and in- fective dermatoses, alongside reports of tumours and pigmented and non-pigmented skin lesions. The ter- minology used for describing structures seen under dermoscopy have been standardized by consensus and previously published [1] . The 2-step algorithm for differ- entiating melanocytic from non-melanocytic tumours has become the foundation on which dermoscopic diag- nosis depends. Furthermore, several algorithms are cur- rently in use to help differentiate between benign and malignant melanocytic neoplasms [1] .
Dermoscopy key points: recommendations from the international dermoscopy society / Bowling, J., Argenziano, G., Azenha, A., Bandic, J., Bergman, R., Blum, A., Cabo, H., Di Stephani, A., Grichnik, J., Halpern, A., Hofman-Wellenhof, R., Johr, R., Kittler, H., Kopf, A., Kreusch, J., Langford, D., Malvehy, J., Marghoob, A., Menzies, S., Ozdemir, F., et al.. - In: DERMATOLOGY. - ISSN 1018-8665. - 214:1(2007), pp. 3-5. [10.1159/000096904]
Dermoscopy key points: recommendations from the international dermoscopy society
Pizzichetta, M A;Zalaudek, I
;
2007-01-01
Abstract
The dermoscopy era is developing momentum. Our greater understanding of the morphological features seen with dermoscopy has corresponded with an exponential rise in dermoscopy publications. Publications have in- cluded conditions as diverse as inf lammatory and in- fective dermatoses, alongside reports of tumours and pigmented and non-pigmented skin lesions. The ter- minology used for describing structures seen under dermoscopy have been standardized by consensus and previously published [1] . The 2-step algorithm for differ- entiating melanocytic from non-melanocytic tumours has become the foundation on which dermoscopic diag- nosis depends. Furthermore, several algorithms are cur- rently in use to help differentiate between benign and malignant melanocytic neoplasms [1] .Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
